More encouraging clinical research in the field of Low Level Laser to improve Parkinson’s Disease, published in BMC Neurology. The work carried out by Liebert, et al (2021), was described as a “prospective proof-of-concept study”, that showed improvements in clinical signs of Parkinson’s disease using photobiomodulation (Low Level Laser Therapy).
Read the full Report.
In summary the study outlined:
Background: Parkinson’s disease is a porgressive neurodegenerative disease with you cure and few treatment option. It has a high incidence in ageing populations and is potentially a COVID-19 sequela. Photobiomodulation has been successfully used in animal models to reduce the signs of Parkinson’s and to protect dopaminergic neutrons.
Objective: A combination of transcranial and remote treatment was employed to inform on best practice for a larger randomised placebo controlled trial (PCT).
Methods: 12 participants with idiopathic Parkinson’s disease were recruited. 6 began 12 weeks of transcranial, intranasal and abdominal Low Level Laser Therapy. The other 6 were waitlisted for 14 weeks before commencing the same therapy protocols. Participants were assessed for mobility, motor skills, balance and cognition before treatment began, after 4 weeks of treatment and after 12 weeks of treatment.
Results: Measures of mobility, cognition, dynamic balance and fine motor skills were significantly improved with Low Level Laser to improve Parkinson’s for 12 weeks and up to 1 year. Improvements between individuals varied, and many continued for up to one year with sustained home treatment. No side effects were observed.
Interestingly, a similar report was published in 2018 on Parkinson’sDisease.Net. This report also discussed how ear infrared light (NIr), a low level laser or LED (light emitting diode) is “a new neuroprotective approach being tested in labs for use in treating Parkinson’s disease and numerous other diseases and conditions such as Alzheimer’s, stroke, and ALS. It is a “repair-oriented” therapy aimed at stabilising defective neurons.”
A recent study into the improvement of endothelial function associated with recovery from Covid-19 patients, demonstrated the possibility of Low Level Laser Therapy for eliminating endothelial dysfunction. If the brain is deprived of oxygen it suffers from synaptic dysfunction and degeneration / loss of neutrons, leading to grey and white mayor atrophy, cognitive dysfunction and the development of Parkinson’s disease. Consequently, Low Level Laser to Improve Parkinson’s disease, eliminates inflammation for the restoration of reduced cerebral blood flow and hypo metabolism.
Please also to referent to our Services:
Low Level Laser for Parkinson’s Disease.
Please Contact us to discuss how we may help.